The pyridinium-2-carbaldoximes with quinolinium carboxamide moiety were designed and synthesised as cholinesterase reactivators. The prepared compounds showed intermediate-to-high inhibition of both cholinesterases when compared to standard oximes. Their reactivation ability was evaluated in vitro on human recombinant acetylcholinesterase (hrAChE) and human recombinant butyrylcholinesterase (hrBChE) inhibited by nerve agent surrogates (NIMP, NEMP, and NEDPA) or paraoxon. In the reactivation screening, one compound was able to reactivate hrAChE inhibited by all used organophosphates and two novel compounds were able to reactivate NIMP/NEMP-hrBChE. The reactivation kinetics revealed compound 11 that proved to be excellent reactivator of paraoxon-hrAChE better to obidoxime and showed increased reactivation of NIMP/NEMP-hrBChE, although worse to obidoxime. The molecular interactions of studied reactivators were further identified by in silico calculations. Molecular modelling results revealed the importance of creation of the pre-reactivation complex that could lead to better reactivation of both cholinesterases together with reducing particular interactions for lower intrinsic inhibition by the oxime.

Department of Chemistry Faculty of Science University of Hradec Kralove Hradec Kralove Czech Republic

Department of Medicinal Chemistry and Pharmacology Daejeon Republic of Korea

Department of Physicochemical Drug Analysis Faculty of Pharmacy Jagiellonian University Medical College Krakow Poland

Division of Bio and Drug Discovery Korea Research Institute of Chemical Technology Daejeon Republic of Korea

Zobrazit více v PubMed

Eddleston M. Novel clinical toxicology and pharmacology of organophosphorus insecticide self-poisoning. Annu Rev Pharmacol Toxicol 2019;59:341–60. PubMed

Pope CN, Brimijoin S.. Cholinesterases and the fine line between poison and remedy. Biochem Pharmacol 2018;153:205–16. PubMed PMC

Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004;38:151–216. PubMed

Thiermann H, Worek F, Kehe K.. Limitations and challenges in treatment of acute chemical warfare agent poisoning. Chem Biol Interact 2013;206:435–43. PubMed

Ashani Y, Bhattacharjee AK, Leader H, et al. . Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators. Biochem Pharmacol 2003;66:191–202. PubMed

Masson P, Nachon F.. Cholinesterase reactivators and bioscavengers for pre- and post-exposure treatments of organophosphorus poisoning. J Neurochem 2017;142(Suppl 2):26–40. PubMed

Karasova JZ, Kvetina J, Tacheci I, et al. . Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs. Toxicol Lett 2017;273:20–5. PubMed

Soukup O, Korabecny J, Malinak D, et al. . In vitro and in silico evaluation of non-quaternary reactivators of AChE as antidotes of organophosphorus poisoning – a new hope or a blind alley? Med Chem 2018;14:281–92. PubMed

Pashirova TN, Braïki A, Zueva IV, et al. . Combination delivery of two oxime-loaded lipid nanoparticles: time-dependent additive action for prolonged rat brain protection. J Control Release 2018;290:102–11. PubMed

Franjesevic AJ, Sillart SB, Beck JM, et al. . Resurrection and reactivation of acetylcholinesterase and butyrylcholinesterase. Chemistry 2019;25:5337–71. PubMed PMC

Radić Z, Sit RK, Kovarik Z, et al. . Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem 2012;287:11798–809. PubMed PMC

Zorbaz T, Mišetić P, Probst N, et al. . Pharmacokinetic evaluation of brain penetrating morpholine-3-hydroxy-2-pyridine oxime as an antidote for nerve agent poisoning. ACS Chem Neurosci 2020;11:1072–84. PubMed

Horn G, de Koning MC, van Grol M, et al. . Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: analysis of reactivation and inhibition kinetics in vitro. Toxicol Lett 2018;299:218–25. PubMed

Kovarik Z, Katalinić M, Sinko G, et al. . Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase. Chem Biol Interact 2010;187:167–71. PubMed

Onder S, David E, Tacal O, et al. . Hupresin retains binding capacity for butyrylcholinesterase and acetylcholinesterase after sanitation with sodium hydroxide. Front Pharmacol 2017;8:713. PubMed PMC

Zorbaz T, Malinak D, Maraković N, et al. . Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents. J Med Chem 2018;61:10753–66. PubMed

Zorbaz T, Malinak D, Kuca K, et al. . Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes. Chem Biol Interact 2019;307:16–20. PubMed

Gorecki L, Andrys R, Schmidt M, et al. . Cysteine-targeted insecticides against A. gambiae acetylcholinesterase are neither selective nor reversible inhibitors. ACS Med Chem Lett 2020;11:65–71. PubMed PMC

Ellman GL, Courtney KD, Andres V, Feather-Stone RM.. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95. PubMed

Worek F, von der Wellen J, Musilek K, et al. . Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase. Arch Toxicol 2012;86:1379–86. PubMed

Martínez-Rosell G, Giorgino T, De Fabritiis G.. PlayMolecule ProteinPrepare: a web application for protein preparation for molecular dynamics simulations. J Chem Inf Model 2017;57:1511–6. PubMed

Varela-Rial A, Majewski M, Cuzzolin A, et al. . SkeleDock: a web application for scaffold docking in PlayMolecule. J Chem Inf Model 2020;60:2673–7. PubMed

Musil K, Florianova V, Bucek P, et al. . Development and validation of a FIA/UV-vis method for pK(a) determination of oxime based acetylcholinesterase reactivators. J Pharm Biomed Anal 2016;117:240–6. PubMed

Malinak D, Nepovimova E, Jun D, et al. . Novel group of AChE reactivators—synthesis, in vitro reactivation and molecular docking study. Molecules 2018;23:2291. PubMed PMC

Gorecki L, Soukup O, Kucera T, et al. . Oxime K203: a drug candidate for the treatment of tabun intoxication. Arch Toxicol 2019;93:673–91. PubMed

Kuca K, Cabal J, Jung YS, et al. . Reactivation of human brain homogenate cholinesterases inhibited by Tabun using newly developed oximes K117 and K127. Basic Clin Pharmacol Toxicol 2009;105:207–10. PubMed

Lee HM, Ahn S, Lee H-Y, et al. . Comparison of plasma and brain exposure levels of bis-pyridinium oximes KR-22839 and KR-26256 with asoxime and obidoxime in mice. Bull Korean Chem Soc 2019;40:5–6.

Komloova M, Musilek K, Horova A, et al. . Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early myasthenia gravis treatment. Bioorg Med Chem Lett 2011;21:2505–9. PubMed

Musilek K, Komloova M, Zavadova V, et al. . Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage—initial study for Myasthenia gravis implications. Bioorg Med Chem Lett 2010;20:1763–6. PubMed

Musilek K, Komloova M, Holas O, et al. . Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage—implications for early Myasthenia gravis treatment. Eur J Med Chem 2011;46:811–8. PubMed

Meek EC, Chambers HW, Coban A, et al. . Synthesis and in vitro and in vivo inhibition potencies of highly relevant nerve agent surrogates. Toxicol Sci 2012;126:525–33. PubMed

O'Brien RD. Insecticides: action and metabolism. 1st ed. New York, NY: Academic Press; 1967.

Chatonnet A, Lockridge O.. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J 1989;260:625–34. PubMed PMC

Allgardsson A, Berg L, Akfur C, et al. . Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6. Proc Natl Acad Sci U S A 2016;113:5514–9. PubMed PMC

Masson P, Froment MT, Bartels CF, Lockridge O.. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase. Biochem J 1997;325:53–61. PubMed PMC

Chambers C, Luo C, Tong M, et al. . Probing the role of amino acids in oxime-mediated reactivation of nerve agent-inhibited human acetylcholinesterase. Toxicol in Vitro 2015;29:408–14. PubMed